Physician profile
Chantel Nicole Garcia Tarbett
NPI 1952666406
$48,209.28
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.73 · 2020: $19.40 · 2021: $12.98 · 2022: $19K · 2023: $3,153 · 2024: $15K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24K · Honoraria: $4,957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24,238.78 |
| Honoraria | $4,956.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $42,709.64 | 2022-2025 | Optilight |
| Oculus, INC. | $5,036.90 | 2024 | Pentacam/Myopia Master/Pentacam Axl Wave, Na, Keratograph 5m |
| Johnson & Johnson Vision Care, INC. | $90.55 | 2019-2024 | Acuvue |
| Alcon Vision LLC | $84.89 | 2023-2025 | Precision 1, Total30 |
| Tarsus Pharmaceuticals, INC. | $58.67 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $56.13 | 2023-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $48.34 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $40.72 | 2024-2025 | Humphrey Hfa, Forum |
| Biotissue Holdings INC. | $25.15 | 2025 | |
| Bausch & Lomb Americas INC. | $22.57 | 2024 | Miebo |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sun Pharmaceutical Industries INC. | $16.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chantel Garcia Tarbett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.